Is There an Entity of Radiation-Induced Chronic Myeloid Leukemia? Report of a Case and Brief Review of the Literature

J Clin Exp Hematop. 2020;60(1):24-25. doi: 10.3960/jslrt.19044.

Authors

Isao Miyoshi¹, Masakazu Mori², Ichiro Yamasaki³, Masanori Daibata⁴

Affiliations

¹ Department of Internal Medicine, Tosatamura Hospital, Kochi, Japan.
² Department of Hematology, Kochi Medical School, Kochi University, Nankoku, Japan.
³ Department of Urology, Kochi Medical School, Kochi University, Nankoku, Japan.
⁴ Department of Microbiology and Infection, Kochi Medical School, Kochi University, Nankoku, Japan.

No abstract available

Keywords: Secondary chronic myeloid leukemia; primary cancer; radiotherapy.

Publication types

Case Reports
Letter
Review

MeSH terms

Aged
Antineoplastic Agents / therapeutic use
Dasatinib / therapeutic use
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
Leukocytosis / drug therapy
Leukocytosis / etiology
Male
Prostatic Neoplasms / radiotherapy*
Radiotherapy, Conformal / adverse effects*

Substances

Antineoplastic Agents
Dasatinib